Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) major shareholder J.H. Whitney Equity Partners V sold 8,346,059 shares of the business’s stock in a transaction on Tuesday, October 21st. The stock was sold at an average price of $9.00, for a total value of $75,114,531.00. Following the transaction, the insider directly owned 20,544,696 shares of the company’s stock, valued at $184,902,264. The trade was a 28.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.
Aveanna Healthcare Price Performance
AVAH stock opened at $9.12 on Friday. The business’s 50-day moving average is $8.45 and its two-hundred day moving average is $6.12. The firm has a market capitalization of $1.91 billion, a P/E ratio of 114.00 and a beta of 2.05. Aveanna Healthcare Holdings Inc. has a 1 year low of $3.67 and a 1 year high of $10.32.
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last announced its quarterly earnings data on Monday, May 22nd. The company reported $0.04 EPS for the quarter. The business had revenue of $450.53 million during the quarter. Aveanna Healthcare had a negative return on equity of 54.56% and a net margin of 0.85%. On average, analysts expect that Aveanna Healthcare Holdings Inc. will post -0.06 EPS for the current year.
Institutional Investors Weigh In On Aveanna Healthcare
Wall Street Analyst Weigh In
A number of equities research analysts have recently weighed in on the stock. Zacks Research lowered shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a report on Monday. Weiss Ratings restated a “hold (c)” rating on shares of Aveanna Healthcare in a research report on Wednesday, October 8th. Truist Financial dropped their target price on shares of Aveanna Healthcare from $6.00 to $5.00 and set a “hold” rating on the stock in a research report on Wednesday, July 16th. UBS Group boosted their price target on shares of Aveanna Healthcare from $8.00 to $9.00 and gave the company a “neutral” rating in a research report on Monday, October 13th. Finally, JPMorgan Chase & Co. raised Aveanna Healthcare from an “underweight” rating to a “neutral” rating and raised their price objective for the stock from $6.00 to $10.00 in a report on Thursday, September 18th. Three equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, Aveanna Healthcare currently has an average rating of “Hold” and a consensus target price of $8.08.
Get Our Latest Analysis on Aveanna Healthcare
About Aveanna Healthcare
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Featured Articles
- Five stocks we like better than Aveanna Healthcare
- What is Put Option Volume?
- Warner Bros. Bidding War Potential: How High Could WBD Shares Go?
- How to start investing in penny stocks
- Analysts Eye 30% Upside in Netflix After Q3 Earnings Crash
- High Flyers: 3 Natural Gas Stocks for March 2022
- O’Reilly Automotive’s Stock Price Uptrend Will Continue in 2026
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
